Tech Company Financing Transactions
Curavit Clinical Research Funding Round
Osage Venture Partners, Narrow Gauge Ventures and Royal Street Ventures participated in a $5 million Series A funding round for Curavit Clinical Research. The funding round was announced on 11/14/2022.
Transaction Overview
Company Name
Announced On
11/14/2022
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand DCT capabilities, partnerships, and market adoption of its virtual CRO services and platform for prescription and non-prescription digital therapeutics trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
18 Larch Lane
Scarsdale, NY 10583
USA
Scarsdale, NY 10583
USA
Phone
Undisclosed
Email Address
Overview
Founded in 2019 by industry veterans with three decades' experience at the intersection of clinical research and digital technology, Curavit is purpose-built to deliver the future of clinical research to innovative clients in biotech, academic research, and digital therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joel Morse
Chief Medical Officer
Pam Diamond
Chief Operating Officer
Jay Collier
Browse more venture capital transactions:
Prev: 11/14/2022: Pineapple Labs venture capital transaction
Next: 11/14/2022: Validic venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs